Aureus Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Aureus Asset Management's LLY Position: Q2 2026 in Review
Aureus Asset Management reduced its Eli Lilly (LLY) stake by 16% in Q2 2026, selling an estimated $663K and leaving 3,359 shares worth $4.03M. The position accounts for 0.24% of the portfolio, ranked #52.
Aureus Asset Management first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Aureus Asset Management held 3,359 shares of Eli Lilly worth $4.03M as of Q2 2026.
- Aureus Asset Management sold 649 Eli Lilly shares in Q2 2026, an estimated $663K.
- Eli Lilly made up 0.24% of Aureus Asset Management's portfolio in Q2 2026, its #52 holding.
- Aureus Asset Management first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Aureus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.